Summary:
The MARS-17 Clinical Trial for Adults with Osteoarthritis (OA) Knee Pain
The MARS-17 clinical trial is testing an investigational drug (the “study drug”) in people living with osteoarthritis (OA) knee pain. If you have OA in one or both knees, you may qualify to join this trial.
Why is the MARS-17 Clinical Trial being done?
The MARS-17 clinical trial is testing an investigational drug called GSK3858279 (the “study drug”), in people living with osteoarthritis (OA) knee pain. What is learned in this trial may help people with OA knee pain in the future. The study drug or placebo, study visits, and study assessments will be provided at no cost to you.
Considering the MARS-17 clinical trial?
You may be eligible to participate in this trial if you:
- Are 40 to 80 years of age
- Have been diagnosed with OA
- Have had OA symptoms in one or both knees for at least 6 months
- Still have knee pain despite current or previous drug treatments
You will also need to meet additional requirements; the study doctor will review these with you.
Before choosing to participate in a clinical trial, you should always speak to your family doctor to find out more information about clinical research.